Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio: Chapterised Sessions

Published: 11 November 2021

  • Views:

    Views Icon 1761
  • Likes:

    Heart Icon 3

Overview

Full programme

  • Views:

    Views Icon 1761
  • Likes:

    Heart Icon 3

Overview

This chapterised on-demand version of the broadcast "Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter Portfolio" sees event Chair Didier Tchétché (Clinic Pasteur, Toulouse, FR) joined by an internationally-respected panel, as they explore key elements of the PASCAL platform. Dr Sam Dawkins (John Radcliffe Hospital, UK) explores its practical application for MR, Dr Nicole Karam (European Hospital Georges Pompidou, FR) for TR; whilst Dr Andreas Ruck (Karolinska University Hospital, SE) provides additional insight with a case-based review of its successful, safe application for Tricuspid Valve repair. Prof Jörg Hausleiter (Ludwig-Maximilians Universitat, Munich, DE) looks to the future of TR treatment, with a review of the EVOQUE replacement system. Prof Michael Böhm provides insight from a heart failure perspective throughout the discussions.

 

The presentations and discussions are set against the back-drop of a live case from the Heart Center Leipzig, under the guidance with Prof Philipp Lurz with Prof Peter Ludike.

This programme was supported by

Learning objectives

  • To discuss the clinical evidence of PASCAL repair system in the treatment of MR and TR
  • To learn from case examples how the PASCAL repair system improves outcomes of patients with MR and TR
  • To participate in a step-by-step LIVE demonstration of percutaneous mitral leaflet repair with the PASCAL repair system

Audience

  • Interventional Cardiologists
  • Cardiologists

Series overview

Part 1

Event Introduction and the PASCAL Platform for MR Treatment

Dr Didier Tchétchè provides a brief introduction to proceedings, including key features and applications of the PASCAL platform, before Dr Sam Dawkins examines the PASCAL platform's role in the treatment of Mitral Regurgitation.

1 session

  • Introduction and The Pascal Platform for MR Treatment

    Watch now

Part 2

PASCAL MR Live Case – Patient Presentation and Strategy

Prof Philipp Lurz and the Leipzig team are joined by Prof Peter Lüdike to outline patient presentation and discuss case strategy.

1 session

  • PASCAL MR Live Case – Patient Presentation and Strategy

    Watch now

Part 3

PASCAL Platform – Successful and Durable Treatment of MR

Dr Sam Dawkins returns to continue his review of the PASCAL platform for use in Mitral Regurgitation, presenting key data from the CLASP study, and a case example. He further reports on his single-centre experience.

1 session

  • PASCAL Platform – Successful and Durable Treatment of MR

    Watch now

Part 4

PASCAL MR Live Case and Panel Discussion

The studio panel rejoin Prof Philip Lurz, Prof Peter Lüdike and the rest of the Leipzig team for an update on the live case.

1 session

  • PASCAL MR Live Case and Panel Discussion

    Watch now

Part 5

The PASCAL Platform for TR Treatment

Dr Nicole Karam reviews the PASCAL platform for TR treatment, addressing significant clinical improvement in patients with challenging tricuspid anatomy, whilst drawing on German and Swiss multi-centre experience.

1 session

  • The PASCAL Platform for TR Treatment

    Watch now

Part 6

PASCAL Platform – Safe and Successful Treatment of TR

In a review of PASCAL's record of safe and effective treatment of Tricuspid Regurgitation, Dr Andreas Ruck shares experience for optimal results, including its ease to optimise and re-grasp, and the very low risk of leaflet or chordal damage.

1 session

  • PASCAL platform – Safe and Successful Treatment of TR

    Watch now

Part 7

Live Case Wrap-up and Panel Discussion

The panel rejoin Leipzig Heart Center for Prof Lurz's summary of the live case, whilst session Chair Didier Tchetche canvasses the opinions of the studio panel.

1 session

  • Live Case Wrap-up and Panel Discussion

    Watch now

Part 8

The Future of TR Treatment with the Tricuspid Replacement System, and Event Summary

Prof Jorg Hausleiter looks to the future of TR treatment, including examining the 6-month results of the TRISCEND study whilst sharing positive early experience with the EVOQUE transfemoral system. Session Chair Didier Tchetche discusses key learnings from the event.

1 session

  • The Future of TR Treatment With the Tricuspid Replacement System, and Summary

    Watch now

Faculty biographies